Vascular Parkinsonism in Moyamoya: Microvascular Biopsy and Imaging Correlates

Annals of Neurology

Volumn 54, Issue 6, 2003, Pages 836-840

  Tan, Eng King ^a,b,c   Chan, Ling Ling ^a   Yu, Gui Xia ^a   Rumpel, Helmut ^a   Wilder Smith, Einar ^d   Wong, Meng Cheng ^a,b  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b NATIONAL NEUROSCIENCE INSTITUTE   (Singapore)

^c Singapore Health Services   (Singapore)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANGIOGRAPHY; ARTICLE; BLOOD VESSEL BIOPSY; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DISEASE PREDISPOSITION; FEMALE; HUMAN; IMAGING; MOYAMOYA DISEASE; MUSCLE HYPERTROPHY; PARKINSONISM; PRIORITY JOURNAL; RISK FACTOR; SMOOTH MUSCLE FIBER; TRANSMISSION ELECTRON MICROSCOPY; VASCULAR PARKINSONISM;

ARTERIOLES; CEREBRAL ANGIOGRAPHY; CEREBRAL INFARCTION; FEMALE; HUMANS; MICROCIRCULATION; MIDDLE AGED; MOYAMOYA DISEASE; MUSCLE, SMOOTH, VASCULAR; PARKINSON DISEASE;

EID: 0344233097     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.10783     Document Type: Article

References (12)

1. Masuda J, Ogata J, Yamaguchi T. Moyamoya disease. In Barnett HJM, Mohr JP, Stein BM, eds. Stroke: pathophysiology, diagnosis and management. 3rd ed. New York: Churchill Livingstone, 2000;815-832.
2. Natori Y, Ikezaki K, Matsushima T, Fukui M. "Angiographic moyamoya" its definition, classification, and therapy. Clin Neurol Neurosurg 1997;99(suppl 2):S168-S172.
3. Winikates J, Jankovic J. Clinical correlates of vascular parkinsonism. Arch Neurol 1999;56:98-102.
4. FitzGerald PM, Jankovic J. Lower body parkinsonism: evidence of vascular etiology. Mov Disord 1989;4:249-260.
5. Ondo W, Chan LL, Levy JK. Vascular parkinsonism: clinical and MRI correlates predicting motor improvement after lumbar puncture. Mov Disord 2002;17:91-97.
6. Zijlmans JCM, Thijssen HOM, Vogels OJM, et al. MRI in patients suspected of vascular parkinsonism. Neurology 1995;45:2183-2188.
7. Wong TY, Klein R, Couper DJ, et al. Retinal microvascular abnormalities and incident stroke: the Atherosclerosis Risk in Communities Study. Lancet 2001;358:1134-1140.
8. Gordon DL, Bendixen BH, Adams HP Jr, et al. Interphysician agreement in the diagnosis of subtypes of acute ischemic stroke: implications for clinical trials. The TOAST Investigators. Neurology 1993;43:1021-1027.
9. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35-41.
10. Hong YH, Ahn TB, Oh CW, Jeon BS. Hemichorea as an initial manifestation of moyamoya disease: reversible striatal hypoperfusion demonstrated on single photon emission computed tomography. Mov Disord 2002;6:1380-1383.
11. Wong MC, Yu GX, Ng YK, et al. Microvascular endothelial "blebbing": an in vivo study of stroke patients. Neurology 2003;60(5)Supp 1:A63 (abstract).
12. Yamamoto M, Aoyagi M, Fukai N, et al. Increase in prostaglandin E(2) production by interleukin-1-beta in arterial smooth muscle cells derived from patients with moyamoya disease. Circ Res 1999;85:912-918.